Related Experiment Video
Updated: May 29, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
[Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases]
1Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University.
Rinsho Shinkeigaku = Clinical Neurology
|September 17, 2011
Summary
Aquaporin 4 (AQP4) astrocytopathy, without anti-AQP4 antibodies, characterizes Baló's disease. This autoantibody-independent mechanism may also occur in multiple sclerosis (MS) and neuromyelitis optica (NMO).
Area of Science:
- Neuroimmunology
- Central Nervous System Pathology
- Demyelinating Diseases
Context:
- Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) are CNS demyelinating diseases.
- NMO is associated with anti-aquaporin 4 (AQP4) antibodies, leading to astrocyte necrosis.
- Baló's disease presents with concentric demyelination rings, previously considered an MS variant.
Purpose:
- To investigate the role of AQP4 in Baló's disease pathogenesis.
- To differentiate Baló's disease from MS and NMO based on AQP4 involvement.
- To explore autoantibody-independent mechanisms in CNS demyelination.
Summary:
- Baló's disease shows extensive AQP4 loss in astrocytes, independent of anti-AQP4 antibodies.
- Unlike NMO, Baló's disease patients were seronegative for anti-AQP4 antibodies.
- This suggests AQP4 astrocytopathy is a key feature of Baló's disease, potentially occurring in MS and NMO as well.
Impact:
- Reclassifies Baló's disease as potentially distinct from antibody-mediated NMO.
- Highlights autoantibody-independent astrocytopathy as a common pathway in demyelinating diseases.
- Opens new avenues for diagnosing and treating MS, NMO, and Baló's disease.
